Moderna has abandoned its application for a U.S. patent covering its Covid-19 vaccine that has been the subject of a heated dispute with the National Institutes of Health over the invention of a key component of the shot on.wsj.com
@WSJ4 years ago
A second Covid-19 vaccine was cleared for use in the U.S. by health regulators. Vaccinations with the Moderna shot could start as soon as Monday. on.wsj.com
@snopes.com3 years ago
FDA Panel Endorses Booster Shot for J&J COVID-19 Vaccine
@abcnews.go.com4 years ago
U.S. regulators post positive review of Pfizer vaccine data
@snopes.com3 years ago
FDA Panel Endorses Lower-Dose Moderna COVID Shot for Booster
@abcnews.go.com4 years ago
U.S. regulators post positive review of Pfizer vaccine data
@WSJ3 years ago
Johnson & Johnson has asked U.S. health regulators to authorize a booster dose for its Covid-19 vaccine, citing studies showing it improved protection among adults who previously received a single shot on.wsj.com
@WSJ4 years ago
Pfizer and BioNTech plan to ask health regulators soon to authorize their Covid-19 vaccine, after more data show it is working safely. If the FDA gives a thumbs-up, the shot would be the first to go into use in the U.S. Here’s what we know and don’t know. on.wsj.com
